Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Increasing dosing intervals for biologics in atopic dermatitis‐why, who, when and how?
Increasing dosing intervals for biologics in atopic dermatitis‐why, who, when and how?
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
M. E. Jacobson
,
C. M. Boesjes
,
M. S. de Bruin‐Weller
,
M. de Graaf
,
R. Y. Morimoto
,
E. L. Simpson
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Journal of the European Academy of Dermatology and Venereology
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://onlinelibrary.wiley.com/doi/10.1111/jdv.20534
Similar Items
Addressing potential bias when assessing safety of biologics and JAK inhibitors in atopic dermatitis
by: Lian F. van der Gang, et al.
Published: (2026)
Reassuring evidence on infection risk with dupilumab in atopic dermatitis: Lessons from real‐world evidence
by: Lian F. van der Gang, et al.
Published: (2025)
Translating 6‐year trial safety data of upadacitinib in atopic dermatitis into clinical practice
by: Lian F. van der Gang, et al.
Published: (2026)
The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of use
by: M. E. Jacobson, et al.
Published: (2024)
Efficacy of abrocitinib and dupilumab in itch‐dominant atopic dermatitis: An analysis of 2 trials
by: Jonathan I. Silverberg, et al.
Published: (2026)